Hims & Hers Health (HIMS)
NYSE Market Closed
Hims & Hers Health, Inc. is a consumer-focused telehealth company that connects patients with licensed medical providers through digital platforms branded as Hims and Hers. The company targets common, often stigmatized health and wellness categories by combining online consultations, personalized treatment plans, and direct-to-consumer fulfillment.
Its services cover areas such as sexual health, hair loss, dermatology, mental health, primary care, and weight management. Products may include generic and branded prescription medicines, compounded prescriptions where permitted, over-the-counter treatments, supplements, cosmetics, and related wellness items. The platform is designed to make care feel more accessible and discreet, with asynchronous or virtual provider interactions, electronic medical records, and pharmacy fulfillment integrated into the customer experience.
Hims & Hers operates primarily on a cash-pay model rather than relying on insurance reimbursement. Customers typically pay directly for visits, subscriptions, and products, which gives the company more control over pricing and user experience but also makes affordability and retention important drivers of growth. Its subscription model is a key part of the business, supporting recurring revenue and ongoing engagement for treatments that require continuity.
The company is available across the United States and has expanded into select international markets, including the UK. Its competitive position rests on brand recognition, digital marketing, clinical network management, convenience, and the ability to personalize offerings at scale. As with other healthcare platforms, it operates within a highly regulated environment covering prescribing practices, pharmacy operations, advertising, privacy, and state-by-state medical rules.
Last updated
- Market Cap
- 6.37B
- P/E
- —
- P/FCF
- 95.21
- P/S
- 2.69
- Enterprise Value
- 7.12B
- Sector
- Health Care
- Industry
- Offices and Clinics of Doctors of Medicine
- Address
- 2269 CHESTNUT ST, SAN FRANCISCO, CA, 94123
Hims & Hers Debt-Funded Expansion Tests Its Global Telehealth Ambitions
Hims & Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recov
Hims & Hers tumbles 15% after earnings miss as GLP-1 transition weighs on results
Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in Focus
Data Breach Alert: Edelson Lechtzin LLP Investigates Hims & Hers, Inc. Data Breach
Hims & Hers in Free Fall: Why Analysts See Nearly 150% Upside
Hims GLP-1 Weight Loss: What Consumers Should Know About the Reported $49 Compounded Semaglutide Pill, Novo Nordisk Response, and Telehealth Prescription Access in 2026
PharmaZee GLP-1 Prescription Information Updated as Novo Nordisk Raises Compounding Concerns and Consumer Interest in Telehealth Semaglutide Access Grows in 2026
Kelley Drye Expands Privacy Practice with Partner Kate Black and Special Counsel Mason Fitch
High Short-Interest Stocks to Buy Before Q1 2026
Hims & Hers Stock Pushes to Highs on Healthcare Rate Cut Frenzy
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS
Hims & Hers (HIMS) Stock Lawsuits: Investors Urged to Act - Hagens Berman
HIMS DEADLINE TOMORROW: ROSEN, A LEADING NATIONAL FIRM, Encourages Hims & Hers Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 25 Deadline in Securities Class Action – HIMS
INVESTOR DEADLINE MONDAY: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - HIMS
HIMS FINAL DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Hims & Hers Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 25 Deadline in Securities Class Action – HIMS
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 6.37B
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 7.12B
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- 14.27
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 2.69
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 189.48
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 3
- EPS
- -0.06
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 95.21
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 22.72
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 66.88M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -2.97%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -0.58%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 2.18
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 1.69
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 1.56
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.36
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 23.88M
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 27.51
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 608.1M | 617.82M | 598.98M | 544.83M | 586.01M |
| Gross profit | 396.79M | 444.44M | 442.06M | 416.2M | 430.69M |
| Operating income | -78.32M | 9.19M | 11.81M | 26.72M | 57.9M |
| EBITDA | -56.37M | 27.28M | 29.48M | 37.19M | 66.17M |
| Net income | -92.12M | 20.6M | 15.77M | 42.51M | 49.49M |
| Basic EPS | -0.4 | 0.09 | 0.07 | 0.19 | 0.22 |
| Diluted EPS | -0.4 | 0.08 | 0.06 | 0.17 | 0.2 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 2.27B | 2.15B | 2.23B | 1.88B | 891.71M |
| Total liabilities | 1.82B | 1.61B | 1.65B | 1.31B | 342.45M |
| Total equity | 446.17M | 540.93M | 580.98M | 562.7M | 549.26M |
| Cash & equivalents | 222.27M | 228.62M | 345.78M | 1.12B | 273.74M |
| Current assets | 1.05B | 767.64M | 845.26M | 1.36B | 446.96M |
| Current liabilities | 618.78M | 404.43M | 450.79M | 272.23M | 280.36M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | 89.36M | 61.31M | 148.72M | -19.12M | 109.09M |
| Investing cash flow | -15.45M | -83.68M | -887.4M | -21.09M | -32.8M |
| Financing cash flow | -77.88M | -97.52M | -39.01M | 889.17M | -23.02M |
| Change in cash | -6.35M | -117.16M | -779.17M | 849.99M | 53.52M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 8-K — Hims & Hers Health, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| form 4 | Form 4 — WELLS DAVID B | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 8-K — Hims & Hers Health, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — WELLS DAVID B | View Filing | |
| form 4 | Form 4 — Payne Christopher D | View Filing | |
| form 4 | Form 4 — Carroll Patrick Harrison | View Filing | |
| edgar index | 8-K — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — Okupe Oluyemi | View Filing | |
| form 4 | Form 4 — Okupe Oluyemi | View Filing | |
| form 4 | Form 4 — Okupe Oluyemi | View Filing | |
| form 4 | Form 4 — Okupe Oluyemi | View Filing | |
| edgar index | SCHEDULE 13G — Hims & Hers Health, Inc. | View Filing | |
| edgar index | SCHEDULE 13G/A — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 8-K — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 10-Q — Hims & Hers Health, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | ARS — Hims & Hers Health, Inc. | View Filing | |
| edgar index | DEF 14A — Hims & Hers Health, Inc. | View Filing | |
| edgar index | DEFA14A — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 144 — Hims & Hers Health, Inc. | View Filing | |
| form 4 | Form 4 — Boughton Soleil | View Filing | |
| form 4 | Form 4 — Okupe Oluyemi | View Filing | |
| form 4 | Form 4 — Okupe Oluyemi | View Filing | |
| form 4 | Form 4 — Okupe Oluyemi | View Filing | |
| form 4 | Form 4 — Okupe Oluyemi | View Filing | |
| form 4 | Form 4 — Okupe Oluyemi | View Filing | |
| form 4 | Form 4 — Okupe Oluyemi | View Filing | |
| form 4 | Form 4 — Okupe Oluyemi | View Filing | |
| form 4 | Form 4 — Okupe Oluyemi | View Filing | |
| form 4 | Form 4 — Okupe Oluyemi | View Filing | |
| form 4 | Form 4 — Okupe Oluyemi | View Filing | |
| form 4 | Form 4 — Okupe Oluyemi | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| form 4 | Form 4 — Dudum Andrew | View Filing | |
| form 4 | Form 4 — Dudum Andrew | View Filing | |
| form 4 | Form 4 — Dudum Andrew | View Filing | |
| form 4 | Form 4 — Dudum Andrew | View Filing | |
| form 4 | Form 4 — Dudum Andrew | View Filing | |
| form 4 | Form 4 — Dudum Andrew | View Filing | |
| form 4 | Form 4 — Dudum Andrew | View Filing | |
| form 4 | Form 4 — Dudum Andrew | View Filing | |
| form 4 | Form 4 — Dudum Andrew | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 144 — Hims & Hers Health, Inc. | View Filing | |
| form 4 | Form 4 — Okupe Oluyemi | View Filing | |
| form 4 | Form 4 — Okupe Oluyemi | View Filing | |
| form 4 | Form 4 — Okupe Oluyemi | View Filing | |
| form 4 | Form 4 — Okupe Oluyemi | View Filing | |
| edgar index | SCHEDULE 13G/A — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| form 4 | Form 4 — Okupe Oluyemi | View Filing | |
| form 4 | Form 4 — Okupe Oluyemi | View Filing | |
| form 4 | Form 4 — Okupe Oluyemi | View Filing | |
| form 4 | Form 4 — Okupe Oluyemi | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 4 — Hims & Hers Health, Inc. | View Filing | |
| edgar index | 144 — Hims & Hers Health, Inc. | View Filing |